Andere talen Karolinska Development AB

Aandelen

KDEV

SE0002190926

Beurs gesloten - Nasdaq Stockholm Andere beurzen 17:17:16 03-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
1,58 ^SEK	0,00%		+0,64%	-6,95%

26/04	Karolinska Development AB (publ) rapporteert resultaten voor het eerste kwartaal eindigend op 31 maart 2024	CI
16/04	Karolinska Development AB (Publ) kondigt aan dat Bjorn Cochlovius zich niet herkiesbaar heeft gesteld	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Interim Report - January-March 2024	26/04
Karolinska Development AB Reports Earnings Results for the First Quarter Ended March 31, 2024	26/04
Notice of Annual General Meeting in Karolinska Development AB (publ)	16/04
Karolinska Development AB Announces That Björn Cochlovius Has Declined Re-Election	16/04
Karolinska Development : portfolio company Umecrine Cognition presents positive safety data from the first part of its Phase 1b/2 study in PBC	22/03
Karolinska Development’s portfolio company Umecrine Cognition presents positive safety data from the first part of its Phase 1b/2 study in PBC	22/03
Karolinska Development Annual Report 2023 published	22/03
Karolinska Development Annual Report 2023 published	22/03
Karolinska Development : portfolio company Aprea Therapeutics receives FDA IND approval and secures funding of USD 34 million	14/03
Karolinska Development’s portfolio company Aprea Therapeutics receives FDA IND approval and secures funding of USD 34 million	14/03
Karolinska Development : portfolio company Biosergen publishes prospectus due to rights issue of units	14/03
Karolinska Development’s portfolio company Biosergen publishes prospectus due to rights issue of units	14/03
Karolinska Development : portfolio company Umecrine Cognition presents preclinical Parkinson's data on golexanolone at AD/PD	06/03
Karolinska Development’s portfolio company Umecrine Cognition presents preclinical Parkinson’s data on golexanolone at AD/PD	06/03
Year-end Report - January-December 2023	16/02
Karolinska Development AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	16/02
Karolinska Development Portfolio Company AnaCardio Completes SEK150 Million Funding Round	17/01
Karolinska Development’s portfolio company AnaCardio secures SEK 50 million as part of its Series A investment round	17/01
AnaCardio AB announced that it has received SEK 150 million in funding from Industrifonden, Karolinska Development AB, Flerie Invest AB	17/01
Karolinska Development's portfolio company OssDsign reports exceptional clinical data for its nanosynthetic bone graft product	09/01

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Karolinska Development AB

Aandelen

KDEV

SE0002190926

Andere talen

Filters